Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Short term Debt (2016 - 2024)

United Health Products (UEEC) has disclosed Short term Debt for 14 consecutive years, with $207500.0 as the latest value for Q3 2024.

  • On a quarterly basis, Short term Debt rose 1.35% to $207500.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $207500.0, a 1.35% increase, with the full-year FY2023 number at $207500.0, up 5087.5% from a year prior.
  • Short term Debt was $207500.0 for Q3 2024 at United Health Products, roughly flat from $207500.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $322856.0 in Q3 2020 to a low of $3207.0 in Q4 2021.
  • A 5-year average of $128954.5 and a median of $158960.0 in 2023 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: tumbled 98.76% in 2021, then skyrocketed 5087.5% in 2023.
  • United Health Products' Short term Debt stood at $322856.0 in 2020, then crashed by 99.01% to $3207.0 in 2021, then increased by 24.73% to $4000.0 in 2022, then surged by 5087.5% to $207500.0 in 2023, then changed by 0.0% to $207500.0 in 2024.
  • Per Business Quant, the three most recent readings for UEEC's Short term Debt are $207500.0 (Q3 2024), $207500.0 (Q2 2024), and $207500.0 (Q1 2024).